Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies
Sponsor: CRISPR Therapeutics AG
Summary
This study will evaluate the long-term safety and efficacy of CRISPR CAR T cellular therapies
Official title: A Long-term Follow-up Study of Subjects With Malignancies Treated With CRISPR CAR T Cellular Therapies
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
70
Start Date
2023-11-22
Completion Date
2038-08
Last Updated
2025-08-14
Healthy Volunteers
No
Conditions
Interventions
Non Interventional
Safety and Efficacy Assessment
Locations (22)
City of Hope
Duarte, California, United States
Cedars Sinai
Los Angeles, California, United States
Stanford
Stanford, California, United States
Yale New Haven Hospital
New Haven, Connecticut, United States
Emory
Atlanta, Georgia, United States
University of Chicago
Chicago, Illinois, United States
University of Kansas
Westwood, Kansas, United States
University of Minnesota
Minneapolis, Minnesota, United States
Washington University Saint Louis
St Louis, Missouri, United States
MSKCC
New York, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
Oregon Health and Science University
Portland, Oregon, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
UT Southwestern
Dallas, Texas, United States
MD Anderson Cancer Center
Houston, Texas, United States
Methodist Hospital-Sarah Cannon
San Antonio, Texas, United States
University of Utah-Huntsman Cancer Institute
Salt Lake City, Utah, United States
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
Peter MacCallum Cancer Center
Melbourne, Victoria, Australia
Sir Charles Gairdner
Nedlands, Australia
Princess Margaret
Toronto, Ontario, Canada
University Hospital Hamburg-Eppendorf
Hamburg, Germany